Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
President Donald Trump Revived a controversial policy targeting on Monday Slash drug costs In the United States, some medications are significantly reduced abroad.
Trump has signed a number of orders, including several different movements to update the efforts known as the “Most Likes Nation”. Trump did not belong to specific nations, but other developed countries will target, because “some of the countries in need of some additional help are good.”
“Basically, it is equal to what we do,” Trump said during the press on Monday. “We will pay the lowest price in the world. Who will receive the lowest price, we will receive, the price we will get.”
White House officials did not disclose which drugs will be applied, but it will affect the trading market and Medicare and Medicaid, he said. Monday’s announcement would be broader than a similar policy that Trump, only those who try to push in the first period applied for Medicare Part B drugs.
Authorities added that leadership will pay special attention to drugs, which are “the greatest difference and greatest expenses and the largest expenses”, which can cover the treatment of popular weight and severe diabetes, GLP-1 medicine.
It is unknown how effective costs will be effective for patients. In post on a social media on Monday, Trump, Drug prices “59%, plus!”
However, Trump in the press event claimed that drug prices were further, 59% and 80%, or “90%.”
The shares of the US Aprhipers were mixed on Monday. Shares Merck shares increased by more than 4% Pfizer and amggen rose over 2%
How to work with Trump’s drug price order
President of Health and Human Services Robert F. Kennedy JR, President Donald Trump, May 12, 2025 speaks in the Roosevelt room of the White House in Washington, DC during a press conference.
Andrew Harnik | Getty pictures
Some of the order aims to negotiate with pharmaceutical companies with drug prices to negotiate drug prices.
“Starting today, the United States will no longer subsidize foreign health services, which said,” Trump “.
He added that “the countries that forcing the Great Pharma were certainly not sure what they feel really comfortable.”
The order directs the US Trade Representative and the Department of Commerce to convey the “Unlocked and Discrimination Policy” in foreign countries to transmit “non-boarding and discrimination policy” abroad.
“Will we try to make sure that countries are not unfair in talks with pharmaceutical companies?” Said an officer. “When these talks are in the negotiations,” it is constantly complaining that “these companies are usually for all countries.
Unlike the United States, several foreign countries provide universal health coverage, which is the only payer of the government, giving it a necessary result, drug prices or determine.
White House officials said they expect discounts for “mutual” actions that solve drug prices abroad.
The Secretary of the Trump’s Order, Health and Human Services Department is aimed at establishing a way to buy US patients directly from manufacturers from direct manufacturers to purchase from manufacturers in the most popular nation.
“We will cut Middlem, and the price of the most beloved nation will facilitate the sale of direct drugs directly to the American citizen,” Trump said.
For 30 days, the secretary also said that in the United States, the United States must set accurate targets to reduce prices in all markets. This will open a round of negotiations between the HHS and the pharmaceutical industry, and the authorities did not present the exact details of the nature of these talks.
If this price goals do not include “Adequate Progress”, HHS Secretary Robert F. Kennedy JR will ensure that the most popular nation is evaluated by the nation’s duties.
The order also combines food and drug adoption to consider expanding the expansion of other developed nations in Canada. Trump Signed a separate executive order Directs to improve food and drug management in April process Which states can apply for lower valuable medications between other measures designed to reduce lower valuable drugs and drug prices.
Monday command also directs the Justice and Federal Trade Commission to aggressively implement the “anti-competition actions” that maintains prices in the United States
The trade department will also “allow low prices to fuel and abroad”.
This is the latest effort to try to report to the US receptive drug prices are more than two or three times higher than them Other developed nations – 10 times more than in certain countries, public policy, thinking of public policy.
The order is a blow to the previously prepared drug industry for TRUP’s recipe medications. Pharmacies argue that the “most popular nation” policy will result in the potential to research and develop new drugs.
The officials of the White House claimed that pharmaceutical companies will receive money after the US “what is for the United States” and the prices are increased there to make additional income.
Pharmacies “should follow the deals of the financial award, and evaluate the value of other nations, health systems and health systems,” he said.
“Other countries should also pay research and development. It is for their benefits,” said Trump on Monday.
Politics can help patients by reducing the recipe for many Americans. The price of more than three large medicines in the United States says it is unavailable A CFF request Since 2022.
Industry, lobbovation against similar Trump plans in the same period. Worked Push the policy In the last months of this period, but a federal judge stalled make an effort after a claim from the drug industry. Biden management then canceled this policy.
White house officials Pressed first The President previously reports that this month that the main reconciliation invoice planned to pass in the coming months the “Most Liked Nation” organizational Republicans, but in politics, drug medicines are related to the achievements of medicine. Several gop members were different from this event.
Patients affect companies
The largest trading group of industry, Phrma, estimated This Trump’s Medicaid proposal may be the cost of pharmacies with more than $ 4 trillion in one year.
Some health policy experts may not be effective in reducing the medicinal costs of “the most popular nation” drug policy.
For example, USC experts said “The world cannot eliminate the main economy of the global drug market, which is 70% of the world’s pharmaceutical benefit”
“We can wait for a choice between deep cuts or loss of poor foreign markets in the US prices,” said the experts said in a report in April.
Americans will pay the same amount of drugs for drugs, low profit and future generations, and the fewer innovations said.
“Total, everyone loses,” said experts.
Other experts said that another legal struggle policy with the pharmaceutical industry could prevent the effect of politics.
However, although the drug industry boosts the decision of the Trump’s implementation, his leadership still has another tool to push drug prices: Medicare drug pricing talks.
Medicare is the main provision of inflation reduction in inflation, which is the power to discuss drug prices for the first recipe with manufacturers in history.
Last month, Trump offered a change in this policy, where drugs were looking for a long time. MPs on both sides of the aisle can accept the idea that proposed the rules that differ between small molecule and biological drugs.
Last week, Trump said he plans to announce tariffs for drugs brought to the United States in the next two weeks. The planned collections aim to increase local drug production.
Including dergmakers Eli lilli and PfizerThey return to this potential positions. Given that some of the companies will be already, they asked the tariffs to be necessary New US production and research and development investments have been announced Since the task of Trump.
Again, Trump last week, increased efforts to re-evaluate drug production. The pharmacies have signed an order that facilitates the way to build new production sites.
Caplan noted that even if the drug industry is pushed back by the executive order, the leadership still has another tool at his disposal: Medicare drugs assessment negotiations.
